Specific binding of semax in different regions of the rat brain.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 17278839)

Published in Dokl Biol Sci on February 06, 2007

Authors

T V V'yunova1, K V Shevchenko, V P Shevchenko, M Yu Bobrov, V V Bezuglov, N F Myasoedov

Author Affiliations

1: Institute of Molecular Genetics, Russian Academy of Sciences, pl. Akademika Kurchatova 46, Moscow, 123182 Russia.

Articles by these authors

[Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration]. Bioorg Khim (2006) 1.56

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J (2000) 1.55

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun (1998) 1.32

Entry of the synthetic ACTH(4-10) analogue into the rat brain following intravenous injection. Neurosci Lett (1991) 1.10

Natural and hybrid ("chimeric") stable regulatory glyproline peptides. Pathophysiology (2005) 1.05

The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo. Dokl Biol Sci (2003) 1.04

Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog. Neurosci Lett (2001) 1.02

[Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases]. Bioorg Khim (2011) 0.99

An invertebrate model of the developmental neurotoxicity of insecticides: effects of chlorpyrifos and dieldrin in sea urchin embryos and larvae. Environ Health Perspect (2001) 0.95

Ex vivo screening of prospective peptide drugs: new approaches. Dokl Biol Sci (2010) 0.94

Role of gangliosides in reception of influenza virus. Eur J Biochem (1982) 0.93

[Free skin radicals in psoriasis and their relationship to oxidation-reduction processes]. Vestn Dermatol Venerol (1973) 0.91

[Analysis of prostaglandins using high performance liquid chromatography of their dansylhydrazides]. Dokl Akad Nauk SSSR (1990) 0.90

Comparison of pharmacokinetics and metabolism of Pro-Gly-Pro-Leu administered intranasally and intravenously in the blood and brain of rats. Dokl Biochem Biophys (2014) 0.90

[Structural-functional study of glycine-and-proline-containing peptides (glyprolines) as potential neuroprotectors]. Bioorg Khim (2009) 0.87

Binding of tripeptide Pro-Gly-Pro labeled at the C-terminal proline residue to plasma membranes of the rat forebrain. Dokl Biol Sci (2008) 0.86

Antiviral properties of structural fragments of the peptide Selank. Dokl Biol Sci (2010) 0.85

Semax prevents functional impairments of avoidance response in rats. Dokl Biol Sci (2013) 0.85

The solid-state catalytic synthesis of tritium labeled amino acids, peptides and proteins. Amino Acids (1995) 0.82

Characteristic features of specific binding of pentapeptide HFPGP labeled at the C-terminal proline residue to rat forebrain plasma membranes. Dokl Biochem Biophys (2014) 0.82

Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10. Neurosci Lett (2007) 0.81

X-ray investigation of gene-engineered human insulin crystallized from a solution containing polysialic acid. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.81

Interaction of docosahexaenoic acid derivatives with mitochondria. Dokl Biol Sci (2007) 0.81

The effect of α-melanocyte-stimulating hormone on early stages of differentiation of mouse embryonic stem cells. Dokl Biol Sci (2013) 0.81

The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system. Neurosci Behav Physiol (2004) 0.81

Expression changes caused by the peptide semax in the intracellular signal pathway genes in rat hippocamp. Dokl Biochem Biophys (2008) 0.80

Degradation of the ACTH(4-10) analog Semax in the presence of rat basal forebrain cell cultures and plasma membranes. Amino Acids (2006) 0.80

Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex. Bull Exp Biol Med (2006) 0.80

[Cholinergic regulation of the sea urchin embryonic and larval development]. Ross Fiziol Zh Im I M Sechenova (2001) 0.80

The effect of semax on animal pain sensitivity in various experimental models. Dokl Biol Sci (2003) 0.80

Sulfation of N-acyl dopamines in rat tissues. Biochemistry (Mosc) (2009) 0.79

[New aspects of biosynthesis and metabolism of N-acyldopamines in rat tissues]. Bioorg Khim (2008) 0.79

Dihydroceramide desaturase activity in tumors. Biochemistry (Mosc) (2002) 0.79

Cannabinoid regulation in identified synapse of terrestrial snail. Eur J Neurosci (2007) 0.79

A putative 'pre-nervous' endocannabinoid system in early echinoderm development. Dev Neurosci (2009) 0.78

Interaction of holothurian triterpene glycoside with biomembranes of mouse immune cells. Int Immunopharmacol (2012) 0.78

Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system. Bull Exp Biol Med (2006) 0.78

[Cerebrovascular and antiaggregative effects of GABA-docosahexaenoyldopamine conjugate]. Eksp Klin Farmakol (2008) 0.77

Antioxidant and neuroprotective properties of N-docosahexaenoyl dopamine. Bull Exp Biol Med (2006) 0.77

[Polyenic acid 5-hydroxytryptamides and 3-hydroxytyramides as tools for studying of the pre-nervous biogenic monoamine functions]. Ross Fiziol Zh Im I M Sechenova (2000) 0.77

[Artificially functionalized polyenoic fatty acids--a new lipid bioregulators]. Bioorg Khim (1997) 0.77

Role of cannabinoid receptor agonists in mechanisms of suppression of central pain syndrome. Bull Exp Biol Med (2006) 0.77

Transcriptomic response of rat hippocampus and spleen cells to single and chronic administration of the peptide selank. Dokl Biochem Biophys (2010) 0.77

[Synthesis of monoepoxides of arachidonic, eicosapentaenoic, and docosahexaenoic acids]. Bioorg Khim (1993) 0.77

Effect of docosahexaenoyl dopamine on the in vitro development of early mouse embryos. Dokl Biol Sci (2012) 0.76

Effects of Semax on Ca2+ responses of human neutrophils. Dokl Biol Sci (2001) 0.76

In vitro effects of anandamide and prostamide e2 on normal and transformed nerve cells. Bull Exp Biol Med (2011) 0.76

[Docosahexaenoyl dopamine in freshwater hydra: effects on regeneration and metabolic changes]. Ontogenez (2010) 0.76

Formation of spatial memory in rats with ischemic lesions to the prefrontal cortex; effects of a synthetic analog of ACTH(4-7). Neurosci Behav Physiol (2009) 0.76

[Gangliosides modulate lipoxygenase oxidation in human lymphocytes]. Biokhimiia (1991) 0.76

[Acute erosive gastropathies]. Arkh Patol (2011) 0.76

Unsaturated fatty acids as endogenous bioregulators. Biochemistry (Mosc) (1998) 0.76

The effect of semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia. Dokl Biochem Biophys (2008) 0.76

Hydrolysis of anandamide and eicosapentaenoic acid ethanolamide in mouse splenocytes. Biochemistry (Mosc) (2000) 0.76

Correction of long-lasting negative effects of neonatal isolation in white rats using semax. Acta Naturae (2012) 0.75

[Artificial therapeutic nutrition using special food mixtures in complex treatment of patients]. Vopr Pitan (1995) 0.75

[Labeling of steroids with tritium]. Bioorg Khim (1983) 0.75

[Preparation and properties of prostaglandin D2 labelled with tritium with high molar radioactivity]. Bioorg Khim (1989) 0.75

[The effect of fluorinated prostaglandins on platelet aggregation]. Eksp Klin Farmakol (1994) 0.75

[Arachidonoyl amino acids and arachidonoyl peptides: synthesis and properties]. Bioorg Khim (2006) 0.75

[Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis]. Arkh Patol (2003) 0.75

[A method for including an anterothoracally located intestinal graft in the enteral feeding process]. Voen Med Zh (1989) 0.75

Comparison of the biological activity of fusicoccin in higher plants with its binding to plasma membranes. Planta (1991) 0.75

Efficacy of the anesthetic protection in one-stage anterior and posterior spinal fusion in surgery of scoliosis. Folia Med (Plovdiv) (2002) 0.75

[Radioreceptor study of [3H]-olanzapine specific binding in the rat frontal cortex and striatum]. Eksp Klin Farmakol (2007) 0.75

[Antiserum reaction to prostaglandin F2 alpha with modified prostaglandins F2]. Dokl Akad Nauk SSSR (1980) 0.75

[Synthesis of tritium-labelled prostaglandin E1 and its binding to human platelets]. Bioorg Khim (1988) 0.75

[Blood thymus hormone content in different types of neoplastic process and its changes as a result of chemotherapy and surgical removal of tumors]. Eksp Onkol (1990) 0.75

Synthesis of highly tritium labeled steroids for evaluation of aromatase and steroidsulfatase activities in endometrial tumors. Bull Exp Biol Med (2006) 0.75

[Clinical significance of lacticoacidemia in patients with meningococcal infection]. Ter Arkh (1976) 0.75

[Stereochemistry of substituting the allyl hydroxyl group with fluorine atom in prostaglandins. Synthesis of 15-fluoro-11,15-dideoxyprostaglandins E1]. Bioorg Khim (1997) 0.75

[Prostaglandin distribution in 2-phase systems and their incorporation into liposomes]. Dokl Akad Nauk SSSR (1983) 0.75

[The use of the atlanten nutrient mixture in artificial feeding]. Voen Med Zh (1995) 0.75

[Electroencephalography monitoring at total and managed hyperthermia to 44 degrees C]. Anesteziol Reanimatol (2003) 0.75

[Variation of ecological status of Norwegian Sea water determined from hydrolytic enzyme activities]. Izv Akad Nauk Ser Biol (2005) 0.75

[Use of rheopolyglucine in severe combined trauma]. Probl Gematol Pereliv Krovi (1977) 0.75

[Changes in regional meningeal immunity in local immunomodulating therapy in patients with acute traumatic intracranial hematomas]. Arkh Patol (2007) 0.75

[Synthesis, pharmacokinetics, and metabolism of the C-terminal tripeptide of dermorphin and its diastereomer]. Bioorg Khim (2008) 0.75

[The dietetic aspects of the treatment of patients with ischemic heart disease]. Voen Med Zh (1995) 0.75

[Early nutrition support for intestinal insufficiency syndrome in spine surgery]. Anesteziol Reanimatol (2004) 0.75

[Some pathophysiological aspects of hyperthermic pharmacotherapy and its clinical use]. Anesteziol Reanimatol (2004) 0.75

[Lipoxygenase oxidation of arachidonic acid in murine splenocytes and its modulation by the lactone ganglioside GM3]. Biokhimiia (1994) 0.75

[A synthesis of tritium-labeled olanzapine]. Bioorg Khim (2005) 0.75

DNA slows dissociation of progesterone receptor-steroid ligand complexes. Steroids (2003) 0.75